Skip to main content
TipRanks
Go Ultimate75% OFF

Wuhan YZY Biopharma Co., Ltd. Class H (2496) Income Statement

1 Followers

Wuhan YZY Biopharma Co., Ltd. Class H Income Statement

Last quarter (Q2 2026), Wuhan YZY Biopharma Co., Ltd. Class H's total revenue was ¥32.69M, an increase of 47.33% from the same quarter last year. In Q2, Wuhan YZY Biopharma Co., Ltd. Class H's net income was ¥-6.17M. See Wuhan YZY Biopharma Co., Ltd. Class H’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
¥ 65.13M¥ 107.81M¥ 11.92M¥ 2.28M¥ 12.18M
¥ 6.17M¥ 85.07M¥ 11.92M¥ 2.28M¥ 12.18M
¥ 94.11M¥ 183.07M¥ 177.37M¥ 177.85M¥ 144.39M
Depreciation and Amortization¥ 4.44M¥ 6.57M¥ 7.32M¥ 6.94M¥ 7.62M
¥ -83.49M¥ -86.95M¥ -157.46M¥ -168.63M¥ -124.61M
¥ -87.93M¥ -98.00M¥ -177.37M¥ -175.58M¥ -132.23M
¥ 5.39M¥ 402.00K¥ -14.34M¥ -13.29M¥ -16.29M
¥ -82.54M¥ -97.60M¥ -190.98M¥ -188.87M¥ -148.52M
¥ -82.54M¥ -97.60M¥ -190.98M¥ -188.87M¥ -148.52M
Per Share Metrics
Basic EPS¥ -0.42¥ -0.50¥ -1.14¥ -0.98¥ -0.77
Diluted EPS¥ -0.42¥ -0.50¥ -1.14¥ -0.98¥ -0.77
Weighted Average Shares Outstanding193.85M193.85M185.11M193.00M193.00M
Weighted Average Shares Outstanding (Diluted)193.85M193.85M185.11M193.00M193.00M

Currency in CNY

Wuhan YZY Biopharma Co., Ltd. Class H Earnings and Revenue History

-300M-150M0150M-9000 %-6000 %-3000 %0 %EarningsProfit Margin202020212022202320242025RevenueEarningsProfit Margin